Zoetis Inc (NYSE:ZTS)
| 161.39 Delayed Data As of Nov 27 |  +1.20 / +0.75%Today’s Change | 90.14 Today|||52-Week Range 176.64 | +21.94% Year-to-Date |
Latest ZTS News | Press Releases
| Why Is a Coronavirus Vaccine Bad News for Some Stocks? Nov 18 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 160.19 |
| Today’s open | 161.62 |
| Day’s range | 160.29 - 161.91 |
| Volume | 853,298 |
| Average volume (3 months) | 1,606,017 |
| Market cap | $76.7B |
Data as of 12:59pm ET, 11/27/2020
Growth & Valuation
| Earnings growth (last year) | +6.13% |
| Earnings growth (this year) | +4.23% |
| Earnings growth (next 5 years) | +10.47% |
| Revenue growth (last year) | +7.47% |
| P/E ratio | 46.5 |
| Price/Sales | 10.19 |
| Price/Book | 28.35 |
Competitors
Data as of 1:00pm ET, 11/27/2020
Financials
| Next reporting date | February 9, 2021 |
| EPS forecast (this quarter) | $0.86 |
| Annual revenue (last year) | $6.3B |
| Annual profit (last year) | $1.5B |
| Net profit margin | 23.96% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Parsippany, New Jersey |
Forecasts
